Academy of Finland  
  Funding decisions 24.06.2021
 
 
 
Year of decision:  
Funding source: Research Council for Biosciences, Health and Environment
Call: 2020 Health from Science, follow-up call for consortia
Project count: 24
Project funding: 3 000 000 €
 
Applicant / Contact person Organisation Project title Decision No. Decision date Funding period Funding
Health from Science, follow-up call for consortia BTY
 
Alitalo, Kari University of Helsinki Treating dementia by blood brain barrier opening to increase glymphatic clearance - From mechanisms to therapeutic applications / Consortium: OPEN_2 335721 17.09.2020 01.01.2021 - 31.12.2022 162 500

Eklund, Lauri University of Oulu Treating dementia by blood brain barrier opening to increase glymphatic clearance - From mechanisms to therapeutic applications / Consortium: OPEN_2 335722 17.09.2020 01.01.2021 - 31.12.2022 162 500

Elo, Laura University of Turku Immunoregulation and Therapeutic Precision in Rheumatoid Arthritis / Consortium: Heal-Art 335434 17.09.2020 01.01.2021 - 31.12.2022 134 374

Haataja, Leena Helsinki University Central Hospital Rhythms in Infant Brain 2: Wearables for Computational Diagnostics and Mobile Monitoring of Treatment (RIB-2) / Consortium: RIB-2 335873 17.09.2020 01.01.2021 - 31.12.2022 62 101

Heinäniemi, Merja University of Eastern Finland Reprogramming of macrophage phenotypes as an early predictor of cardiovascular and metabolic disease development / Consortium: MAP-CAD 335964 17.09.2020 01.01.2021 - 31.12.2022 89 971

Ilen, Elina Aalto University Rhythms in Infant Brain 2: Wearables for Computational Diagnostics and Mobile Monitoring of Treatment (RIB-2) / Consortium: RIB-2 335938 17.09.2020 01.01.2021 - 31.12.2022 30 788

Juuti, Anne Tuulikki Helsinki University Central Hospital Individualized treatments for obesity based on mitochondrial biology / Consortium: MitoPower4WeightLoss 335447 17.09.2020 01.01.2021 - 31.12.2022 100 000

Kaikkonen-Määttä, Minna University of Eastern Finland Reprogramming of macrophage phenotypes as an early predictor of cardiovascular and metabolic disease development / Consortium: MAP-CAD 335973 17.09.2020 01.01.2021 - 21.12.2022 108 205

Kiviniemi, Vesa University of Oulu Treating dementia by blood brain barrier opening to increase glymphatic clearance - From mechanisms to therapeutic applications / Consortium: OPEN_2 335720 17.09.2020 01.01.2021 - 31.12.2022 162 500

Laakso, Markku University of Eastern Finland Reprogramming of macrophage phenotypes as an early predictor of cardiovascular and metabolic disease development / Consortium: MAP-CAD 335974 17.09.2020 01.01.2021 - 31.12.2022 107 214

Lahesmaa, Riitta Liisa Maria University of Turku Immunoregulation and Therapeutic Precision in Rheumatoid Arthritis / Consortium: Heal-Art 335435 17.09.2020 01.01.2021 - 31.12.2022 176 028

Lähdesmäki, Harri Aalto University Immunoregulation and Therapeutic Precision in Rheumatoid Arthritis / Consortium: Heal-Art 335436 17.09.2020 01.01.2021 - 31.12.2022 131 899

Lönnberg, Tapio University of Turku Reprogramming of macrophage phenotypes as an early predictor of cardiovascular and metabolic disease development / Consortium: MAP-CAD 335977 17.09.2020 01.01.2021 - 31.12.2022 108 736

Mustjoki, Satu University of Helsinki Immunoregulation and Therapeutic Precision in Rheumatoid Arthritis / Consortium: Heal-Art 335432 17.09.2020 01.01.2021 - 31.12.2022 207 750

Myllylä, Teemu University of Oulu Treating dementia by blood brain barrier opening to increase glymphatic clearance - From mechanisms to therapeutic applications / Consortium: OPEN_2 335723 17.09.2020 01.01.2021 - 31.12.2022 162 500

Pietiläinen, Kirsi University of Helsinki Individualized treatments for obesity based on mitochondrial biology / Consortium: MitoPower4WeightLoss 335443 17.09.2020 01.01.2021 - 31.12.2022 100 000

Pihlajamäki, Jussi University of Eastern Finland Individualized treatments for obesity based on mitochondrial biology / Consortium: MitoPower4WeightLoss 335444 17.09.2020 01.01.2021 - 31.12.2022 100 000

Pirinen, Eija University of Helsinki Individualized treatments for obesity based on mitochondrial biology / Consortium: MitoPower4WeightLoss 335445 17.09.2020 01.01.2021 - 31.12.2022 100 000

Roivainen, Anne University of Turku Reprogramming of macrophage phenotypes as an early predictor of cardiovascular and metabolic disease development / Consortium: MAP-CAD 335975 17.09.2020 01.01.2021 - 31.12.2022 159 554

Ruusuvuori, Pekka University of Turku Reprogramming of macrophage phenotypes as an early predictor of cardiovascular and metabolic disease development / Consortium: MAP-CAD 335976 17.09.2020 01.01.2021 - 31.12.2022 126 320

Räsänen, Okko Tampere University Rhythms in Infant Brain 2: Wearables for Computational Diagnostics and Mobile Monitoring of Treatment (RIB-2) / Consortium: RIB-2 335872 17.09.2020 01.01.2021 - 31.12.2022 53 613

Silvennoinen, Olli Tampere University Immunoregulation and Therapeutic Precision in Rheumatoid Arthritis / Consortium: Heal-Art 335437 17.09.2020 01.01.2021 - 31.12.2022 199 949

Vanhatalo, Sampsa University of Helsinki Rhythms in Infant Brain 2: Wearables for Computational Diagnostics and Mobile Monitoring of Treatment (RIB-2) / Consortium: RIB-2 335788 17.09.2020 01.01.2021 - 31.12.2022 153 498

Virtanen, Kirsi Turku University Hospital Individualized treatments for obesity based on mitochondrial biology / Consortium: MitoPower4WeightLoss 335446 17.09.2020 01.01.2021 - 31.12.2022 100 000